CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,023,010
- in 6 filings, $3.0M under 10b5-1 plans
Net −$3,023,010. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Barrow Robert −$1.9M Chief Executive Officer sold 2% of stake
- Sullivan Mark −$514K Chief Legal Officer sold 3% of stake
- Karlin Daniel −$397K Chief Medical Officer sold 1% of stake
- Roberts Brandi −$123K Chief Financial Officer sold <1% of stake
- Wiley Matthew T. −$113K Chief Commercial Officer sold <1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-14 | Liao Carrie VP, Controller&Acct Principal | Grant or award | +75,000 | 478,430 | ||
| 2023-03-14 | Karlin Dan Chief Medical Officer | Grant or award | +125,000 | 385,505 | ||
| 2023-03-14 | Wernli Miri Halperin Executive President | Grant or award | +100,000 | 1,375,000 | ||
| 2023-03-14 | Greenway Schond L. Chief Financial Officer | Grant or award | +175,000 | 1,445,000 | ||
| 2023-03-01 | Karlin Dan Chief Medical Officer | Sale | −3,577 | $3.51 | $13K | 260,505 |
| 2023-03-01 | Barrow Robert Chief Executive Officer | Sale | −8,273 | $3.51 | $29K | 238,959 |
| 2022-12-21 | Barrow Robert Chief Executive Officer | Sale | −3,861 | $2.69 | $10K | 247,232 |
| 2022-12-21 | Karlin Dan Chief Medical Officer | Sale | −1,211 | $2.69 | $3K | 264,082 |
| 2022-10-27 | Karlin Dan Chief Medical Officer | Sale | −644 | $3.00 | $2K | 265,293 |
| 2022-10-25 | Karlin Dan Chief Medical Officer | Sale | −541 | $2.81 | $2K | 265,937 |
| 2022-10-25 | Barrow Robert Chief Executive Officer | Sale | −1,207 | $2.81 | $3K | 251,093 |
| 2022-10-18 | Barrow Robert Chief Executive Officer | Sale | −1,220 | $3.11 | $4K | 252,300 |
| 2022-09-27 | Karlin Dan Chief Medical Officer | Sale | −640 | $5.87 | $4K | 266,478 |
| 2022-09-26 | Karlin Dan Chief Medical Officer | Sale | −565 | $5.51 | $3K | 267,118 |
| 2022-09-26 | Barrow Robert Chief Executive Officer | Sale | −1,264 | $5.51 | $7K | 253,520 |
| 2022-09-16 | Barrow Robert Chief Executive Officer | Sale | −1,350 | $7.26 | $10K | 254,784 |
| 2022-08-31 | Karlin Dan Chief Medical Officer | Sale | −1,204 | $11.67 | $14K | 267,683 |
| 2022-08-31 | Barrow Robert Chief Executive Officer | Sale | −1,228 | $11.67 | $14K | 256,134 |
| 2022-08-16 | Barrow Robert Chief Executive Officer | Sale | −20,350 | $0.68 | $14K | 3,860,438 |
| 2022-08-11 | CRYSTAL ROGER Director | Grant or award | +89,286 | 89,286 |
Page 8 of 12 · 225 trades